Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Troponin T1, skeletal, slow (TNNT1) is a critical protein component of the troponin complex located on the thin filaments of slow-twitch (Type I) skeletal muscle fibers. It serves as the tropomyosin-binding subunit, anchoring the troponin complex to the muscle filament and playing a pivotal role in the calcium-mediated regulation of muscle contraction. When calcium binds to troponin C, TNNT1 facilitates the conformational shift of tropomyosin, exposing myosin-binding sites on actin and allowing for cross-bridge cycling. Mutations in the TNNT1 gene are primarily associated with Nemaline Myopathy type 5, a severe autosomal recessive muscle disorder characterized by progressive muscle weakness and respiratory insufficiency. While most current skeletal muscle troponin activators like Reldesemtiv target the fast isoform (TNNT3), TNNT1 is an emerging target for gene replacement therapies and small molecules aimed at restoring muscle function in slow-twitch fibers. Understanding TNNT1 is essential for developing treatments for neuromuscular diseases that specifically affect postural and endurance-based muscle groups.
Skeletal muscle troponin activators (SSTAs) bind to the fast skeletal troponin complex, but research into slow skeletal troponin (TNNT1) modulation is primarily focused on gene replacement therapy and stabilizing the troponin-tropomyosin complex to enhance calcium sensitivity and force production in slow-twitch fibers.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Troponin T1, skeletal, slow (TNNT1).